Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)
Completed
Merck Sharp & Dohme Corp.
Phase 4
2005-08-01
The primary objective of this study was to determine whether children ages 6-11 years prefer
desloratadine RediTabs (2.5 mg) or a marketed competitor (Zyrtec® 5 mg Chewable Tablets). The
secondary objectives of this study were to compare acceptance of the two attributes, taste
and feeling in the mouth, of desloratadine 2.5 mg RediTabs and Zyrtec® 5 mg Chewable Tablets
Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03829)(COMPLETED)
Completed
Merck Sharp & Dohme Corp.
Phase 3
2004-11-01
This study was conducted to compare the taste acceptability of Zyrtec syrup with
desloratadine syrup in children. Children between 6 and 11 years of age received 5 mL of each
syrup, separated by 15 to 20 minutes on a single day.
Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03826)
Completed
Merck Sharp & Dohme Corp.
Phase 3
2004-11-01
This study was conducted to compare the taste acceptability of Zyrtec syrup with
desloratadine syrup in children. Children between 6 and 11 years of age received 5 mL of each
syrup, separated by 15 to 20 minutes on a single day.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.